Celltrion announced on Friday that its biosimilar Avtozma, a version of the autoimmune disease treatment Actemra (active ingredient tocilizumab), has received product approval from the US Food and ...

Tocilizumab-anoh is the seventh biosimilar by Celltrion to receive FDA approval, enhancing their treatment portfolio. Avtozma, the third biosimilar to Actemra, has received FDA approval for ...

Figure 1. Chemical Structure of Azilsartan Medoxomil (PubChem CID: 11238823) Figure 2. Chemical Structure of Azilsartan (PubChem CID: 9825285) ...